BALPHARMA.BOBALPHARMA.BOBSE
Loading
Operating Income PerformanceStrong
Percentile Rank93
3Y CAGR+9.9%
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

3Y CAGR
+9.9%/yr
vs +8.9%/yr prior
Acceleration
+0.9pp
Accelerating
Percentile
P93
Near historical high
vs 3Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$197.89M-7.8%
2024$214.57M+21.1%
2023$177.23M+18.8%
2022$149.18M+6.1%
2021$140.64M+638.3%
2020$-26.13M-122.3%
2019$117.05M+10.5%
2018$105.95M+36.9%
2017$77.40M-3.6%
2016$80.28M-